EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,885,000 | +1.4% | 500,000 | +25.0% | 0.02% | +5.9% |
| Q2 2023 | $7,776,000 | -31.5% | 400,000 | 0.0% | 0.02% | -32.0% |
| Q1 2023 | $11,348,000 | -2.9% | 400,000 | 0.0% | 0.02% | -10.7% |
| Q4 2022 | $11,692,000 | +77.0% | 400,000 | +60.0% | 0.03% | +75.0% |
| Q3 2022 | $6,605,000 | -40.5% | 250,000 | 0.0% | 0.02% | -36.0% |
| Q2 2022 | $11,108,000 | +193.6% | 250,000 | +400.0% | 0.02% | +177.8% |
| Q2 2018 | $3,783,000 | +387.5% | 50,000 | +150.0% | 0.01% | +350.0% |
| Q2 2016 | $776,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |